Mar 27, 2018 Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles Learn More
Mar 19, 2018 Cellectar Biosciences Granted Orphan Drug Designation for CLR 131 to Treat Neuroblastoma Learn More
Mar 19, 2018 Cellectar Biosciences to Host 2017 Financial Results and Business Update Conference Call on March 22, 2018 Learn More